Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2025Frontiers in PharmacologyOpen Access

Editorial: Plant metabolites in drug discovery: the prism perspective between plant phylogeny, chemical composition, and medicinal efficacy, volume IV

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDa‐Cheng HaoRSRichard W. SpjutDDDayi Deng

Discussion

Loading...

Member takes

Overview

This editorial reviews insights on pharmacophylomics and phylogenomics in developing bioactive compounds, suggesting new trajectories in drug discovery for diverse plant taxa.

Key Points

  • Pharmacophylomics predicts therapeutic utilities while preserving biodiversity, crucial for innovative drug discovery.
  • Eight studies in Volume IV highlight the predictive power of pharmacophylogeny across various taxa, emphasizing metabolite potential.
  • Integration of advanced techniques like AI in resource mapping can enhance efficiency and support sustainable practices.
  • Future efforts must focus on exploring unexplored taxonomic spaces, ensuring conservation of medicinal plant resources despite global threats.

Cite This Study

Hao et al. (2025) studied this question.

synapsesocial.com/papers/68af4eaead7bf08b1ead736ehttps://doi.org/10.3389/fphar.2025.1666900
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ethnopharmacological insights into tropical medicinal plants: biodiversity, bioactive compounds, and therapeutic potential for modern drug discovery2026
  2. 2Advances in plant natural products: Biosynthesis, bioengineering, and applications2026
  3. 3Novel Therapeutic Mediators: The Intersection of Pharmacognosy and Ethnopharmacology2025
  4. 4Ethnopharmacology: Engineering Plant-Based Therapeutics2025
  5. 5Multi-omics approaches to medicinal plant-specialized metabolism2026